000			01763 a2200493 4500
005			20250518062025.0
264		0	_c20210329
008			202103s 0 0 eng d
022			_a1938-0666
024	7		_a10.1016/j.clbc.2019.08.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aLiu, Dingxie
245	0	0	_aBRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction. _h[electronic resource]
260			_bClinical breast cancer _c02 2020
300			_a41-50.e8 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aBiomarkers, Tumor _xanalysis
650	0	4	_aBreast Neoplasms _xgenetics
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aDatasets as Topic
650	0	4	_aDisease-Free Survival
650	0	4	_aDown-Regulation
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGene Expression Profiling
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMAP Kinase Signaling System _xgenetics
650	0	4	_aMastectomy
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNeoplasm Recurrence, Local _xepidemiology
650	0	4	_aOligonucleotide Array Sequence Analysis
650	0	4	_aPrognosis
650	0	4	_aProto-Oncogene Proteins B-raf _xmetabolism
650	0	4	_aReceptor, ErbB-2 _xanalysis
650	0	4	_aReceptors, Estrogen _xanalysis
650	0	4	_aReceptors, Progesterone _xanalysis
650	0	4	_aRisk Assessment _xmethods
700	1		_aZhou, Kehua
773	0		_tClinical breast cancer _gvol. 20 _gno. 1 _gp. 41-50.e8
856	4	0	_uhttps://doi.org/10.1016/j.clbc.2019.08.005 _zAvailable from publisher's website
999			_c30138377 _d30138377